Studies noted mild changes in fasting glucose levels in some subjects, reinforcing the need for metabolic monitoring during therapy
Heart-related risks, such as atrial fibrillation or heart failure, become more probable without monitoring hormone levels
practical methods for beating sugar addiction help reduce impulse snacking and stabilize energy
The question is whether psychiatrists should be the ones prescribing them, particularly for patients dealing with both obesity and mental health concerns
Semaglutide, Tirzepatide, Retatrutide, and Beyond While all GLP-1RAs share core mechanisms, important differences exist between these medications: Semaglutide (Ozempic, Wegovy) features weekly dosing and has demonstrated substantial weight loss effects (approximately 15% body weight reduction)